Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Familial endocrine myxolentiginosis

View through CrossRef
AbstractWe present an unusual case of a left atrial myxoma as a feature of a familial mesoectodermal disorder and review the literature. The new term ‘familial endocrine myxolentiginosis’ is proposed, which is descriptive of the major clinical components of the syndrome. Myriad features of this disorder include (1) cardiac myxomas; (2) cutaneous myxomas; (3) multiple lentigines or blue nevi, particularly of the head and neck; (4) bilateral primary pigmented nodular adrenocortical hyperplasia; (5) unusual testicular tumors; (6) pituitary tumors; (7) myxoid fibroadenomas of the breast; (8) myxomatous disorder of the stroma of the breast; (9) ductal adenoma of the breast; and (10) psammomatous melanotic schwannoma. A tentative diagnosis is suggested by identifying two features and a definitive diagnosis is made by three or more features. The clinical and pathologic features of cardiac myxoma in familial endocrine myxolentiginosis are identical to those of familial cardiac myxoma: age < 40 years, atypical locations, multicentric origins, and recurrent presentations. A Venn diagram classification for cardiac myxomas is proposed. We include photographic, echocardiographic, biopsy, and adrenal computerized tomography documentation in our patient. Recognition of this disorder is important because of its clinical, surgical, and genetic implications. The availability of transesophageal echocardiographic technology should allow early diagnosis of this underdiagnosed entity. Clinicians should consider this entity in the differential diagnosis of their patients with any one of these manifestations.
Title: Familial endocrine myxolentiginosis
Description:
AbstractWe present an unusual case of a left atrial myxoma as a feature of a familial mesoectodermal disorder and review the literature.
The new term ‘familial endocrine myxolentiginosis’ is proposed, which is descriptive of the major clinical components of the syndrome.
Myriad features of this disorder include (1) cardiac myxomas; (2) cutaneous myxomas; (3) multiple lentigines or blue nevi, particularly of the head and neck; (4) bilateral primary pigmented nodular adrenocortical hyperplasia; (5) unusual testicular tumors; (6) pituitary tumors; (7) myxoid fibroadenomas of the breast; (8) myxomatous disorder of the stroma of the breast; (9) ductal adenoma of the breast; and (10) psammomatous melanotic schwannoma.
A tentative diagnosis is suggested by identifying two features and a definitive diagnosis is made by three or more features.
The clinical and pathologic features of cardiac myxoma in familial endocrine myxolentiginosis are identical to those of familial cardiac myxoma: age < 40 years, atypical locations, multicentric origins, and recurrent presentations.
A Venn diagram classification for cardiac myxomas is proposed.
We include photographic, echocardiographic, biopsy, and adrenal computerized tomography documentation in our patient.
Recognition of this disorder is important because of its clinical, surgical, and genetic implications.
The availability of transesophageal echocardiographic technology should allow early diagnosis of this underdiagnosed entity.
Clinicians should consider this entity in the differential diagnosis of their patients with any one of these manifestations.

Related Results

Analysis of SMOC2 gene variants in familial and non-familial primary open angle glaucoma Pakistani patients
Analysis of SMOC2 gene variants in familial and non-familial primary open angle glaucoma Pakistani patients
AIM: To find out the association of secreted protein acidic and rich in cysteine (SPARC)-related modular calcium binding 2 (SMOC2) gene variants rs2255680 and rs13208776 with genot...
High tumor copy number variations burden was associated with poor prognosis in patients with endocrine-resistant breast cancer
High tumor copy number variations burden was associated with poor prognosis in patients with endocrine-resistant breast cancer
Abstract Background Several studies have showed alterations in genes were associated with endocrine resistance in breast cancer. Nevertheless, genomic characteristics in p...
Endocrine treatment of breast cancer
Endocrine treatment of breast cancer
Abstract Endocrine manipulation has been recognized as a treatment modality for breast cancer for over 100 years. Oestrogen is an important promoter in the pathogene...
Periodontal disease in patients with familial Mediterranean fever: from inflammation to amyloidosis
Periodontal disease in patients with familial Mediterranean fever: from inflammation to amyloidosis
Background and Objective:  Familial Mediterranean fever stimulates a very intense acute‐phase reactants response and if left untreated eventually leads to amyloidosis. The aim of t...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Endocrine Treatment of Breast Cancer: Current Perspectives, Future Directions
Endocrine Treatment of Breast Cancer: Current Perspectives, Future Directions
Breast cancer remains one of the major causes of death in women, and endocrine treatment is currently one of the mainstay of treatment in patients with estrogen receptor positive b...
Lapatinib Restores Endocrine Sensitivity in Selected Patients with Estrogen Receptor (ER) Positive Metastatic Breast Cancer.
Lapatinib Restores Endocrine Sensitivity in Selected Patients with Estrogen Receptor (ER) Positive Metastatic Breast Cancer.
Abstract Background:Breast cancer cell lines achieve a state of resistance to antiestrogens and to estrogen withdrawal or aromatase inhibitors by utilizing other gro...

Back to Top